These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2687312)
1. Alzheimer's dementia: performance on parallel forms of the dementia assessment battery. Teng EL; Wimer C; Roberts E; Damasio AR; Eslinger PJ; Folstein MF; Tune LE; Whitehouse PJ; Bardolph EL; Chui HC J Clin Exp Neuropsychol; 1989 Dec; 11(6):899-912. PubMed ID: 2687312 [TBL] [Abstract][Full Text] [Related]
2. A neuropsychological test battery for use in Alzheimer disease clinical trials. Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273 [TBL] [Abstract][Full Text] [Related]
3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
4. Effects of oral physostigmine in Alzheimer's disease. Stern Y; Sano M; Mayeux R Ann Neurol; 1987 Sep; 22(3):306-10. PubMed ID: 3674795 [TBL] [Abstract][Full Text] [Related]
5. Effects of aging and of Alzheimer's disease on verbal memory. Antonelli Incalzi R; Capparella O; Gemma A; Marra C; Carbonin PU J Clin Exp Neuropsychol; 1995 Aug; 17(4):580-9. PubMed ID: 7593477 [TBL] [Abstract][Full Text] [Related]
6. Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Pasquier F; Grymonprez L; Lebert F; Van der Linden M Neurocase; 2001; 7(2):161-71. PubMed ID: 11320163 [TBL] [Abstract][Full Text] [Related]
7. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. Jenike MA; Albert MS; Heller H; Gunther J; Goff D J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997 [TBL] [Abstract][Full Text] [Related]
8. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance. Giovagnoli AR; Erbetta A; Reati F; Bugiani O Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206 [TBL] [Abstract][Full Text] [Related]
9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
10. Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. Milberg W; Albert M J Clin Exp Neuropsychol; 1989 Oct; 11(5):605-14. PubMed ID: 2808652 [TBL] [Abstract][Full Text] [Related]
11. [Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery]. Larumbe R Rev Med Univ Navarra; 1997; 41(1):6-11. PubMed ID: 9527716 [TBL] [Abstract][Full Text] [Related]
12. [The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease]. Mormont E; Laurier-Grymonprez L; Baisset-Mouly C; Pasquier F Rev Neurol (Paris); 2003 Sep; 159(8-9):762-6. PubMed ID: 13679718 [TBL] [Abstract][Full Text] [Related]
14. Word list versus story memory in Alzheimer disease and frontotemporal dementia. Wicklund AH; Johnson N; Rademaker A; Weitner BB; Weintraub S Alzheimer Dis Assoc Disord; 2006; 20(2):86-92. PubMed ID: 16772743 [TBL] [Abstract][Full Text] [Related]
15. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis. Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627 [TBL] [Abstract][Full Text] [Related]
16. Neuropsychological characteristics of the dementia syndrome of depression: onset, resolution, and three-year follow-up. McNeil JK Clin Neuropsychol; 1999 May; 13(2):136-46. PubMed ID: 10949155 [TBL] [Abstract][Full Text] [Related]
17. Japanese version of the Frontal Assessment Battery for dementia. Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465 [TBL] [Abstract][Full Text] [Related]
18. Recognition memory span in mildly and moderately demented patients with Alzheimer's disease. Salmon DP; Granholm E; McCullough D; Butters N; Grant I J Clin Exp Neuropsychol; 1989 Aug; 11(4):429-43. PubMed ID: 2760179 [TBL] [Abstract][Full Text] [Related]
19. Calculation and number processing in mild Alzheimer's disease. Deloche G; Hannequin D; Carlomagno S; Agniel A; Dordain M; Pasquier F; Pellat J; Denis P; Desi M; Beauchamp D J Clin Exp Neuropsychol; 1995 Aug; 17(4):634-9. PubMed ID: 7593481 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings. Crowell TA; Paramadevan J; Abdullah L; Mullan M J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]